In this context, recent research associated CD74+ (major histocompatibility complex II-associated invariant chain, MHC-II) macrophages with favorable prognosis and immune contexture in hepatocellular carcinoma [15]. The gene discussed is CD74; the disease is hepatocellular carcinoma.